BioSpace News Archive

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2020 after market close on Monday, August 3, 2020 at 4:30 PM Eastern Time. A press release with second quarter 2020 financial results will be issued after market close that day.

Today, Montagu Private Equity LLP (‘Montagu’), a leading European private equity firm, announced the completion of its acquisition of the RTI Surgical OEM business. Following the acquisition, the OEM business will operate as a standalone company and retain the RTI Surgical name. The new RTI Surgical will further its focus on driving innovation across its tissue, biologics and hardware platforms and strengthening its l

ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience® Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.

The Kaiser Permanente Bernard J. Tyson School of Medicine announced today the permanent installation of Bridge (Science of Speed), a major artwork by Los Angeles conceptual artist Glenn Kaino.

Achieved preliminary record total quarterly revenue of $9.8 million and product sales of $9.5 million, driven by demand for CytoSorb as a treatment of cytokine storm in COVID-19 infection and other illnesses. [20-July-2020] MONMOUTH JUNCTION, N.J. , July 20, 2020 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ:CTSO), a critical care immunotherapy leader using its

In a release issued under the same headline on Monday, July 20th by INmune Bio, Inc. (NASDAQ: INMB) was incorrectly reported with below sentence: The gross proceeds to INmune from this offering are approximately $23.1 million, before deducting underwriting discounts and commissions and other offering expenses payable by INmune. This has been corrected with below: The net proceeds to INmune from this offering are approximately $23.1 millio

EGF THERAMED HEALTH CORP. (CSE:TMED)(OTCQB:EVAHF)(FRA:AUHP) (the “Company”) announces that it will rely on the temporary relief granted pursuant to British Columbia Instrument 51-517 (Temporary Exemption from Certain Corporate Finance Requirements with Deadlines during the Period from June 2 to August 31, 2020) in respect of the filing of business acquisition reports (“BAR”) for its acquisition of a 30% equity interest in Pharmadelic Labs Corp.

JourneyLabs Inc. has announced the hiring of Tim Bush as the new Chief Executive Officer effective immediately.

ClinOne, the leader in virtual clinical trial management announces the appointment of three new members to the Board of Directors in conjunction with the recent completion of a Series A financing.

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2020 of $1.01 per share on the company’s common stock